Light anti-thrombotic regimen for prevention of device thrombosis and/or thrombotic complications after interatrial shunts device-based closure.

CONCLUSIONS: A regimen of 100 mg of ASA for six months after ASD/PFO closure appeared to be both safe and effective in preventing device thrombosis and major bleedings. PMID: 31902564 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31902564?dopt=Abstract

Source: European Journal of Internal Medicine - January 1, 2020 Category: Internal Medicine Authors: Rigatelli G, Zuin M, Dell'Avvocata F, Roncon L, Vassilev D, Nghia N Tags: Eur J Intern Med Source Type: research